L364718, a new CCK antagonist, inhibits biological actions of CCK in conscious dogs
- 1 November 1987
- Vol. 8 (6) , 1061-1064
- https://doi.org/10.1016/0196-9781(87)90137-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The preparation and properties of two new chromogenic substrates of trypsinPublished by Elsevier ,2004
- A new simple mouse model for the in vivo evaluation of cholecystokinin (CCK) antagonists: Comparative potencies and durations of action of nonpeptide antagonistsLife Sciences, 1986
- A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusScience, 1985
- Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumideGastroenterology, 1985
- Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus. Fermentation, isolation and biological properties.The Journal of Antibiotics, 1985
- Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dogRegulatory Peptides, 1984
- Effect of synthetic porcine gastrin-releasing peptide on plasma levels of immunoreactive cholecystokinin pancreatic polypeptide and gastrin in dogsPeptides, 1983
- Preparation and application of Procion Yellow Starch for amylase assayClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- A new cannula for the study of pancreatic function.Journal of Applied Physiology, 1968